• Thumbnail for Selegiline
    Selegiline, also known as L-deprenyl and sold under the brand names Eldepryl, Zelapar, and Emsam among others, is a medication which is used in the treatment...
    193 KB (18,856 words) - 21:38, 8 September 2024
  • Thumbnail for Pharmacology of selegiline
    pharmacology of selegiline is the study of the pharmacodynamic and pharmacokinetic properties of the antiparkinsonian and antidepressant selegiline (L-deprenyl)...
    126 KB (12,912 words) - 05:43, 9 September 2024
  • Thumbnail for Levoamphetamine
    Levoamphetamine (category Selegiline)
    levoamphetamine is a known active metabolite of certain other drugs, such as selegiline (L-deprenyl). Levoamphetamine has been used in the treatment of attention...
    62 KB (6,009 words) - 03:33, 5 September 2024
  • Thumbnail for Monoamine oxidase inhibitor
    complicated by panic disorder or hysteroid dysphoria. Newer MAOIs such as selegiline (typically used in the treatment of Parkinson's disease) and the reversible...
    37 KB (4,019 words) - 16:49, 11 September 2024
  • Thumbnail for Monoaminergic activity enhancer
    Monoaminergic activity enhancer (category Selegiline)
    serotonergic activity. Selegiline's metabolite desmethylselegiline has also been found to be active as a CAE. Aside from selegiline and its metabolites,...
    53 KB (5,645 words) - 05:40, 6 September 2024
  • Thumbnail for Rasagiline
    brain. Rasagiline shows pharmacological differences from the related drug selegiline, including having no amphetamine-like metabolites, monoamine-releasing...
    87 KB (8,551 words) - 05:08, 2 September 2024
  • Thumbnail for Phenylpropylaminopentane
    (PPAP; developmental code name MK-306) is an experimental drug related to selegiline which acts as a catecholaminergic activity enhancer (CAE). PPAP is a CAE...
    28 KB (2,858 words) - 18:57, 1 September 2024
  • Thumbnail for Levmetamfetamine
    Levmetamfetamine (category Selegiline)
    catecholamine releasing activity. It is 1- to 10-fold less potent than selegiline but is 3- to 5-fold more potent than dextromethamphetamine in this action...
    49 KB (4,927 words) - 03:38, 5 September 2024
  • Thumbnail for (R)-1-Aminoindan
    it lacks significant monoamine oxidase inhibition. In addition, unlike selegiline and its amphetamine metabolites, it lacks monoamine reuptake-inhibiting...
    9 KB (692 words) - 09:49, 6 September 2024
  • József Knoll (category Selegiline)
    developing the antiparkinsonian and antidepressant drug selegiline (L-deprenyl). He developed selegiline in the 1960s and subsequently studied the drug and...
    7 KB (574 words) - 02:04, 9 September 2024